Grant✓ Small businesses may apply
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health
- Opportunity #
- PAR-27-053
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.279
- Status
- posted
- Posted
- Aug 31, 2026
- Closes
- Jun 16, 2028
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •Private institutions of higher education
- •City or township governments
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Independent school districts
- •For profit organizations other than small businesses
- •State governments
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Special district governments
- •Public and State controlled institutions of higher education
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Native American tribal governments (Federally recognized)
- •County governments
- •Public housing authorities/Indian housing authorities
- •Small businesses
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Contact
Division of Neuroscience and Behavior (DNB) · NIDA_DNB_BCNB_r61@nih.gov